Cargando…

Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?

Irritable bowel syndrome (IBS) and non-alcoholic fatty liver disease (NAFLD) are amongst the most common gastrointestinal and liver conditions encountered in primary and secondary care. Recently, there has been interest in the apparent co-incidence of NAFLD in patients with IBS mainly driven by impr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Purssell, Huw, Whorwell, Peter J, Athwal, Varinder S, Vasant, Dipesh H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727221/ https://www.ncbi.nlm.nih.gov/pubmed/35069992 http://dx.doi.org/10.4254/wjh.v13.i12.1816

Ejemplares similares

The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study
por: Purssell, Huw, et al.
Publicado: (2023)

Gut-focused hypnotherapy for children and adolescents with irritable bowel syndrome
por: Vasant, Dipesh H, et al.
Publicado: (2020)

Experience and clinical efficacy of gut‐directed hypnotherapy in an Asian population with refractory irritable bowel syndrome
por: Sasegbon, Ayodele, et al.
Publicado: (2022)

The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID‐19 pandemic
por: Noble, Hithin, et al.
Publicado: (2022)

Six vs 12 Sessions of Gut-focused Hypnotherapy for Irritable Bowel Syndrome: A Randomized Trial
por: Hasan, Syed S., et al.
Publicado: (2021)

Mo1423: PATIENT PERSPECTIVES ON REMOTE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME DURING THE COVID-19 PANDEMIC: THE 'NEW NORM’ OR JUST A TEMPORARY SOLUTION?
por: Noble, Hithin, et al.
Publicado: (2022)

Patient satisfaction after remotely delivered gut-directed hypnotherapy for irritable bowel syndrome during the COVID-19 era: implications for future practice
por: Noble, Hithin, et al.
Publicado: (2022)

Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?
por: Vasant, Dipesh H, et al.
Publicado: (2020)

Immune responses in the irritable bowel syndromes: time to consider the small intestine
por: Burns, Grace L., et al.
Publicado: (2022)

Circadian Disruption Primes Myofibroblasts for Accelerated Activation as a Mechanism Underpinning Fibrotic Progression in Non-Alcoholic Fatty Liver Disease
por: Jokl, Elliot, et al.
Publicado: (2023)

Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications
por: Martin, Katherine, et al.
Publicado: (2021)

Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions
por: Donnet, Anne-Sophie, et al.
Publicado: (2022)

Health Technology Adoption in Liver Disease: Innovative Use of Data Science Solutions for Early Disease Detection
por: Bennett, Lucy, et al.
Publicado: (2022)

Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review
por: Ng, Jareth Jun Jie, et al.
Publicado: (2023)

Faecal incontinence—the hidden scourge of irritable bowel syndrome: a cross-sectional study
por: Atarodi, Sima, et al.
Publicado: (2015)

SKYPE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME: Effectiveness and Comparison with Face-to-Face Treatment
por: Hasan, Shariq S., et al.
Publicado: (2019)

Gut‐focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence‐base, practical aspects, and the Manchester Protocol
por: Vasant, Dipesh H., et al.
Publicado: (2019)

COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms
por: Settanni, Carlo Romano, et al.
Publicado: (2021)

Microbial metabolites in non-alcoholic fatty liver disease
por: Zhou, Da, et al.
Publicado: (2019)

Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study
por: Wu, Shanshan, et al.
Publicado: (2022)

Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome
por: Carruthers, Helen R, et al.
Publicado: (2010)

Patients With Irritable Bowel Syndrome Exhale More Hydrogen Than Healthy Subjects in Fasting State
por: Kumar, Sunil, et al.
Publicado: (2010)

The microbiome in non-alcoholic fatty liver disease: associations and implications
por: Lin, Eugenia A., et al.
Publicado: (2014)

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Coronavirus disease 2019 and non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2021)

Trust in Vaccines: Why It Takes More than Good Faith
por: Begg, Norman
Publicado: (2013)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Vitiligo Coexistent with Striae: Association More than Coincidence?
por: Feng, Jiao, et al.
Publicado: (2014)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
por: Garsed, Klara, et al.
Publicado: (2014)

Do Patients With Irritable Bowel Syndrome Exhale More Hydrogen Than Healthy Subjects in Fasting State?
por: Choi, Chang Hwan
Publicado: (2010)

Is Rome III Criteria for Irritable Bowel Syndrome More Useful Than Rome II Criteria in Korea?
por: Park, Moo In
Publicado: (2010)

Covid-19 and Guillain-Barré syndrome: More than a coincidence!
por: El Otmani, H., et al.
Publicado: (2020)

Disparities in Female Oncofertility Care in the United States: More Questions Than Answers
por: Turner, Kati A., et al.
Publicado: (2023)

Identifying and testing candidate genetic polymorphisms in irritable bowel syndrome: association with TNFSF15 and tumor necrosis factor-α
por: Sachdev, Amit H., et al.
Publicado: (2013)

Inter-hemispheric Functional Connections Are More Vulnerable to Attack Than Structural Connection in Patients With Irritable Bowel Syndrome
por: Liu, Guangyao, et al.
Publicado: (2021)

Co-morbid disease in COPD – more than a coincidence
por: Crockett, Alan J, et al.
Publicado: (2007)

Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?
por: Janota, Barbara, et al.
Publicado: (2023)

Are patients with polycystic ovary syndrome more prone to irritable bowel syndrome?
por: Kałużna, Małgorzata, et al.
Publicado: (2022)

The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome
por: Jiang, Wenxi, et al.
Publicado: (2022)

Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver
por: Niikura, Toshihiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_arn2gpsitv00l0eeg4lim3a5tj